^
    Back
    Association details:
    Biomarker:ALK translocation
    Cancer:Soft Tissue Sarcoma
    Drug:Alunbrig (brigatinib) (EGFR inhibitor, ALK inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    04/28/2021
    Excerpt:
    Soft Tissue Sarcoma: Inflammatory Myofibroblastic Tumor (IMT) with Anaplastic Lymphoma Kinase (ALK) Translocation...Preferred Regimen...Brigatinib